| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/2001 | WO2001051032A2 Micronized freeze-dried particles |
| 07/19/2001 | WO2001051030A1 Pharmaceutical formulation and method for pulmonary and oral delivery |
| 07/19/2001 | WO2001051011A2 Condensation products of proteins, whereby azelaic acid is used |
| 07/19/2001 | WO2001051008A2 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050987A2 Treatment of hepatitis c using hyperthermia |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001012133A3 Cosmetic compositions with self-warming component |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005943A3 Lcat recombinant cell line compositions and methods |
| 07/19/2001 | WO2001005821A3 Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001005811A3 Cyclic peptidomimetic urokinase receptor antagonists |
| 07/19/2001 | WO2001005418A3 Tissue regenerating agent |
| 07/19/2001 | WO2001005383A3 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001002549A3 Homomeric and heteromeric ampa receptors |
| 07/19/2001 | WO2001002424A3 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 07/19/2001 | WO2001001998A3 Treatment of endometriosis with antileukoprotease |
| 07/19/2001 | WO2000077043A3 Dna vaccines for pets and sport animals |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000071716A3 Vascular endothelial growth factor dimers |
| 07/19/2001 | WO2000071703A3 Inhibition of histone deacetylase |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000044782A3 Ewing's tumour antigen, nucleic acid and antibodies |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | WO2000040229A3 Synergistic tumorcidal response induced by histamine |
| 07/19/2001 | WO2000039280A3 Leukocyte-derived interferon preparations |
| 07/19/2001 | WO2000031136A9 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 07/19/2001 | WO2000025808A9 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008933 Novel disulfides and thiol compounds |
| 07/19/2001 | US20010008888 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 07/19/2001 | US20010008881 Method for the augmentation of gene expression |
| 07/19/2001 | US20010008764 Heparin binding protein |
| 07/19/2001 | US20010008759 Contacting target cells with member of antibody phage display library |
| 07/19/2001 | US20010008634 Bactericides, fungicides, insecticides |
| 07/19/2001 | US20010008627 Controlling cell accumulation |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2400899A1 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397485A1 Peptide inhibitors of lfa-1/icam-1 interaction |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397396A1 Methods and compositions for obtaining disease protection for animals |
| 07/19/2001 | CA2397386A1 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2397030A1 Methods for treating pancreatic disorders |
| 07/19/2001 | CA2396384A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 07/19/2001 | CA2396237A1 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | CA2396235A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | CA2396157A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/19/2001 | CA2366599A1 Treatment of hepatitis c using hyperthermia |
| 07/18/2001 | EP1116791A1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 07/18/2001 | EP1116727A1 Peptide derivative |
| 07/18/2001 | EP1116726A1 Ethylamine derivatives |
| 07/18/2001 | EP1116490A1 Liver function ameliorating agents |
| 07/18/2001 | EP1116032A1 Gpr10 as a target for identifying weight modulating compounds |
| 07/18/2001 | EP1115886A2 Secreted renilla luciferase |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115876A2 Receptor based antagonists and methods of making and using |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115871A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 07/18/2001 | EP1115869A1 Treatment of wilt diseases |
| 07/18/2001 | EP1115867A1 Human interleukin-b50. therapeutic uses |
| 07/18/2001 | EP1115866A1 Cystine knot growth factor mutants |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115861A2 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115859A2 Hairpin hybridizer molecules for modulation of gene expression |
| 07/18/2001 | EP1115858A2 Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1 |
| 07/18/2001 | EP1115853A2 Analysis of ligand activated nuclear receptors in vivo |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115845A2 Fibrils |
| 07/18/2001 | EP1115840A2 Lineage specific cells and progenitor cells |
| 07/18/2001 | EP1115747A1 Polymer complexes of glucuronoglucanes |
| 07/18/2001 | EP1115745A1 Purification of fibrinogen from fluids by precipitation and hydrophoic interaction chromatography |
| 07/18/2001 | EP1115743A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 07/18/2001 | EP1115742A1 Purification of fibrinogen from milk by use of cation exchange chromatography |
| 07/18/2001 | EP1115741A2 Stereoselective process for enalapril |
| 07/18/2001 | EP1115740A1 Synthetic peptides, conjugation reagents and methods |
| 07/18/2001 | EP1115738A1 Synthesis of cyclic peptides |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115733A1 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/18/2001 | EP1115481A1 Compound storage |
| 07/18/2001 | EP1115452A1 Systems and methods for treating ischemia |